Erin Borger

Chief Executive Officer en ExThera Medical Corp. .

43 años

Health Technology

Consumer Services

Health Services

Perfil

Erin R.
Borger is currently the Chief Executive Officer & Director at ExThera Medical Corp.
Mr. Borger previously worked as a Director at the National Parkinson Foundation, Inc. Mr. Borger also served as an Independent Director at Longeveron, Inc. Mr. Borger completed their undergraduate degree at Wofford College.

Cargos activos de Erin Borger

Empresas	Cargo	Inicio
ExThera Medical Corp. ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA.	Chief Executive Officer	15/11/2023

Todos los cargos activos de Erin Borger

Antiguos cargos conocidos de Erin Borger.

Empresas	Cargo	Fin
LONGEVERON INC.	Director/Board Member	09/06/2023
National Parkinson Foundation, Inc.	Director/Board Member	-

Ver el detalle de la experiencia de Erin Borger.

Formación de Erin Borger.

Wofford College

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Erin Borger.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
LONGEVERON INC.	Health Technology

Empresas privadas	2
National Parkinson Foundation, Inc.	Health Technology
ExThera Medical Corp. ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA.	Health Services